Vanguard Group’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $3.89M | Sell |
4,961,871
-669,064
| -12% | -$549K | ﹤0.01% | 3350 |
|
|
2025
Q3 | $4.06M | Buy |
5,630,935
+975,887
| +21% | +$4.42M | ﹤0.01% | 3340 |
|
|
2025
Q2 | $23.6M | Buy |
4,655,048
+648,313
| +16% | +$2.55M | ﹤0.01% | 2483 |
|
|
2025
Q1 | $12.1M | Buy |
4,006,735
+401,808
| +11% | +$1.47M | ﹤0.01% | 2744 |
|
|
2024
Q4 | $13M | Buy |
3,604,927
+617,349
| +21% | +$1.87M | ﹤0.01% | 2806 |
|
|
2024
Q3 | $5.26M | Buy |
2,987,578
+335,421
| +13% | +$610K | ﹤0.01% | 3258 |
|
|
2024
Q2 | $4.14M | Hold |
2,652,157
| – | – | ﹤0.01% | 3333 |
|
|
2024
Q1 | $5.17M | Buy |
2,652,157
+283,703
| +12% | +$495K | ﹤0.01% | 3290 |
|
|
2023
Q4 | $3.34M | Buy |
2,368,454
+84,848
| +4% | +$109K | ﹤0.01% | 3427 |
|
|
2023
Q3 | $3.61M | Sell |
2,283,606
-17,108
| -0.7% | -$31.7K | ﹤0.01% | 3382 |
|
|
2023
Q2 | $4.97M | Buy |
2,300,714
+206,457
| +10% | +$451K | ﹤0.01% | 3306 |
|
|
2023
Q1 | $4.4M | Buy |
2,094,257
+954,131
| +84% | +$2.09M | ﹤0.01% | 3367 |
|
|
2022
Q4 | $2.5M | Buy |
1,140,126
+593
| +0.1% | +$1.4K | ﹤0.01% | 3584 |
|
|
2022
Q3 | $3.42M | Hold |
1,139,533
| – | – | ﹤0.01% | 3516 |
|
|
2022
Q2 | $3.23M | Hold |
1,139,533
| – | – | ﹤0.01% | 3592 |
|
|
2022
Q1 | $6.1M | Buy |
1,139,533
+26,342
| +2% | +$149K | ﹤0.01% | 3427 |
|
|
2021
Q4 | $8.31M | Buy |
1,113,191
+206,450
| +23% | +$1.72M | ﹤0.01% | 3323 |
|
|
2021
Q3 | $8.23M | Buy |
906,741
+311,539
| +52% | +$1.86M | ﹤0.01% | 3363 |
|
|
2021
Q2 | $2.9M | Buy |
595,202
+300,097
| +102% | +$1.28M | ﹤0.01% | 3845 |
|
|
2021
Q1 | $1.31M | Buy |
295,105
+44,958
| +18% | +$211K | ﹤0.01% | 3951 |
|
|
2020
Q4 | $971K | Buy |
250,147
+16,297
| +7% | +$59.6K | ﹤0.01% | 3835 |
|
|
2020
Q3 | $755K | Buy |
233,850
+11,912
| +5% | +$48.9K | ﹤0.01% | 3724 |
|
|
2020
Q2 | $985K | Hold |
221,938
| – | – | ﹤0.01% | 3618 |
|
|
2020
Q1 | $621K | Buy |
221,938
+56,355
| +34% | +$243K | ﹤0.01% | 3621 |
|
|
2019
Q4 | $690K | Sell |
165,583
-900
| -0.5% | -$3.48K | ﹤0.01% | 3727 |
|
|
2019
Q3 | $583K | Buy |
166,483
+39,410
| +31% | +$145K | ﹤0.01% | 3782 |
|
|
2019
Q2 | $652K | Buy |
127,073
+2,407
| +2% | +$16.3K | ﹤0.01% | 3781 |
|
|
2019
Q1 | $960K | Buy |
124,666
+101,157
| +430% | +$720K | ﹤0.01% | 3633 |
|
|
2018
Q4 | $163K | Sell |
23,509
-24,937
| -51% | -$209K | ﹤0.01% | 3931 |
|
|
2018
Q3 | $551K | Buy |
48,446
+579
| +1% | +$6.34K | ﹤0.01% | 3833 |
|
|
2018
Q2 | $610K | Buy |
47,867
+87
| +0.2% | +$2.06K | ﹤0.01% | 3792 |
|
|
2018
Q1 | $1.77M | Buy |
47,780
+12,852
| +37% | +$602K | ﹤0.01% | 3503 |
|
|
2017
Q4 | $1.71M | Buy |
34,928
+4,213
| +14% | +$259K | ﹤0.01% | 3474 |
|
|
2017
Q3 | $2.17M | Sell |
30,715
-394
| -1% | -$18.3K | ﹤0.01% | 3371 |
|
|
2017
Q2 | $1.5M | Buy |
31,109
+14
| +0% | +$655 | ﹤0.01% | 3466 |
|
|
2017
Q1 | $1.52M | Buy |
31,095
+5,613
| +22% | +$257K | ﹤0.01% | 3466 |
|
|
2016
Q4 | $767K | Sell |
25,482
-7,661
| -23% | -$314K | ﹤0.01% | 3641 |
|
|
2016
Q3 | $1.48M | Buy |
33,143
+1,734
| +6% | +$74.9K | ﹤0.01% | 3479 |
|
|
2016
Q2 | $1.22M | Buy |
31,409
+17,150
| +120% | +$797K | ﹤0.01% | 3548 |
|
|
2016
Q1 | $787K | Buy |
14,259
+1,908
| +15% | +$145K | ﹤0.01% | 3662 |
|
|
2015
Q4 | $1.7M | Buy |
12,351
+1,450
| +13% | +$206K | ﹤0.01% | 3453 |
|
|
2015
Q3 | $1.56M | Sell |
10,901
-242
| -2% | -$55.2K | ﹤0.01% | 3478 |
|
|
2015
Q2 | $2.89M | Buy |
+11,143
| New | +$3.46M | ﹤0.01% | 3258 |
|
Other funds holding ATYR
RA
GCP
